Can a lighter chemo punch still knock out lung cancer when paired with immunotherapy?
Disease control
Completed
This completed Phase 4 trial tested two different doses of chemotherapy (standard and low-dose) combined with the immunotherapy drug Sintilimab in 20 people with advanced squamous non-small cell lung cancer. The goal was to see if the lower-dose combination could shrink tumors an…
Phase: PHASE4 • Sponsor: People's Hospital of Quzhou • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC